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ABSTRACT:    
 
This study demonstrates highly dynamic spatial and temporal pattern of 
SULF1/SULF2 expression in a number of neuronal cell types growing in normal 
culture medium that included their transient nuclear mobilisation. Their nuclear 
translocation became particularly apparent during cell proliferation as both 
SULF1/SULF2 demonstrated not only cell membrane associated expression, their 
known site of function but also transient nuclear mobilisation during nuclear cell 
division. Nuclear localisation was apparent not only by immunocytochemical staining 
but also confirmed by immunoblotting staining of isolated nuclear fractions of C6, 
U87 and N2A cells. Immunocytochemical analysis demonstrated rapid nuclear exit of 
both SULF1/SULF2 following cell division that was slightly delayed but not blocked in 
a fraction of the polyploid cells observed in C6 cells. The overexpression of both 
Sulf1 and Sulf2 genes in C6 and U87 cells markedly promoted in vitro growth of 
these cells accompanied by nuclear mobilisation while inhibition of both these genes 
inhibited cell proliferation with little or no nuclear SULF1/SULF2 mobilisation. 
SULF1/SULF2 activity in these cells thus demonstrated a clear co-ordination of 




 Dynamic SULF1/2 mobilisation to nucleus during cell cycle 
 SULF1/2 co-ordinate extracellular cell signalling with nuclear role in cell cycle 
 SULF1/2 overexpression increases cell proliferation while their inhibition 
reduces growth 
 




Sulfatase enzymes constitute a large family of proteins detected in many tissues 
many of which are located in the lysosome within the cell [1-3]. Lysosomal sulfatases 
cleave a range of sulfated carbohydrates including sulfated glycosaminoglycans and 
glycolipids. Sulfatases play important roles including the degradation of sulfated 
glycosaminoglycans and glycolipids in the lysosome, and in remodelling of sulfated 
glycosaminoglycans in the extracellular space.  In addition to the intracellular 
sulfatases, later studies also detected a new family of sulfatases called Sulf1 and 
Sulf2 that from their molecular structure could be predicted to have an extracellular 
function [4, 5]. While the catalytic region including the catalytic site of the new 
sulfatases showed high homology to most previously described intracellular 
sulfatases, SULF1/SULF2 enzymes in contrast included not only a hydrophobic 
signal for secretion but also a large segment of highly basic hydrophilic domain 
ideally suited to dock such enzymes to the cell membrane [4, 5]. Their extracellular 
function became further apparent from the extracellular localisation of these 
enzymes on the cell membrane. Their function on the cell membrane was soon 
discovered to relate to cell signalling events as these enzymes promoted some cell 
signalling pathways requiring desulfated HSPG co-receptor function to facilitate 
ligand receptor interaction while inhibiting those cell signalling pathways requiring 
sulfated HSPG function [6-8]. Catalytic analyses showed SULF1/SULF2 to 
specifically desulfate 6-O sulfates required for ligand receptor interaction of certain 
growth factors e.g. FGF, VEGF signalling that could thus be inhibited by these 
enzymes. The activities of other growth factors/signalling molecules sequestered in 
ECM in contrast can be promoted by their release from ECM by SULF1/SULF2 
desulfation to faciltate ligand receptor interaction. Membrane associated 
SULF1/SULF2 expression and their cell signalling function has been confirmed by 
many research groups.  Our recent study, however, also detected their expression in 
the nuclei of some normal in vivo neuronal cells [9] and some cancer cells 
(unpublished). Our in vitro analysis of some neuronal cell lines further confirmed 
SULF1/SULF2 expression in a proportion of the nuclei of such cells. SULF1/SULF2 
expression in the nucleus of such cells appeared highly dynamic and transient which 
in this study was found to relate to nuclear cell division. The levels of SULF1/SULF2 
expression were markedly reduced in high density cell cultures with non-detection in 
the nucleus. The precise levels of SULF1/SULF2 expression in a cell thus were 
highly variable during different phases of growth and corresponded to the specific 
phase of cell proliferation. 
 
Materials and Methods: 
 
Cell culture, transfection and nocodazole block: All cells (C6, U87, N2A and SH-
SY5Y) obtained from ATCC were grown in Dulbecco’s modified Eagle’s 
(DMEM) medium with 10%FCS. Human Sulf1 and Sulf2 cDNA constructs cloned in 
pcDNA3 described previously [10-12] were transfected into C6 and U87 cells for 
overexpression analysis. Sulf1 and Sulf2 were transfected with an EGFP expression 
vector while the control cells were transfected with EGFP/pcDNA3 alone using the 
Bio-Rad TransFectin reagent. To enrich the mixed population of transfected cells, 
the normal growth medium was changed to DMEM/10%FCS with 800μg/ml G418 
following 48 hour of growth in the normal medium. RNAi vectors for Sulf1/Sulf2 
inhibition in U87 cells were constructed using the shRNAi.2 (Clonetech) vector by the 
addition of hairpins targeting 240bp-exon 6 of Sulf1: 
AAACGAGAAAGATTATGGAAC; and 240bp-exon 6 of Sulf2: 
TACGTCCACAACCACAACACC. These were then co-transfected along with 
pcDNA3.1 to confer G418 resistance.  Transfected cells were allowed to recover and 
selected in the presence of G418 for 3 weeks. Neutralisation antibodies at 200ng/ml 
antibody to SULF1 (C) or SULF2 (D) were used to inhibit SULF1/SULF2 in C6 cells 
as previously described [12]. Transfected and si-RNA inhibited cells grown on Lab-
Tek II chamber slides following 3 weeks of in vitro growth in G418 containing 
medium as well as antibody treated cells were used for SULF1/SULF2 
immunocytochemical staining.  
 
To synchronise cell division in vitro, C6 cells following 1 day growth in vitro were 
treated with 200ng/ml nocodazole for 16 hours to arrest cells at G2/M stage before 
washing the cells with the fresh culture medium to remove all trace of nocodazole 
before replacement with 10%FCS DMEM to follow recovery. The cells were fixed 
after different time intervals to follow recovery. 
 
Cell Synchronisation and Flow Cytometry: C6 cells were cultured in complete 
medium for 24 hours before being treated with 200 ng/ml nocodazole for 16 hours to 
block cells in the G2/M stage of the cell cycle. The following day, cells were released 
from the block and allowed to continue through the cycle via addition of fresh media. 
Cells were then collected at various time points of 0, 1, 3, 4, 6, 8, and 24 hours 
following release from block in conjunction with an asynchronised control which 
consisted of untreated cells. At each time point, cells were harvested by 
trypsinisation followed by addition of 2 ml of fresh media and cell suspensions 
transferred to FACS tubes. Cell suspensions were transferred to 3ml round-bottom 
FACS tubes (Invitrogen) and centrifuged (500g, 5 min, 4°C). Cell pellets were 
washed in 1 ml PBS and were resuspended in 300 μl of PBS and gently vortexed 
while adding 700μl of ice-cold 70 % ethanol drop-wise to the cell suspension. After 
fixation, the cell pellets washed once with PBS, and resuspended by vortexing in a 
propidium-iodide staining buffer (10mM Tris PH 8.0, 150mM NaCl, 0.1% NP- 40, 10 
μg/ml RNAseA, 50μg/ml propidium Iodide) for 45 min at 4oC in the dark. Following 
incubation, cells were centrifuged at 500g for 5 min and resuspended in 300μl PBS 
before DNA content was determined using a BD Canto II analyser with PI detected in 
the phycoerythrin (PE) channel with linear amplification and a total of 10,000 events 
collected for each sample. Data was plotted on a dot plot where each individual dot 
represented a single event or cell and a single population of cells was selected by 
drawing a box or gate around the cells. This population was used to generate a 
histogram to compare to DNA content (x-axis) with number of cells or events (y-
axis). The resulting graph is a cell cycle profile where the different phases of the cell 
cycle, namely G0/1, S and G2/M were identified by the peaks and troughs. The 
percentage of cells in each phase of the cell cycle was analysed using ModFit LT 
software, USA. 
 
Cell Fractionation: Cell fractionation was performed essentially as described before 
[13]. Briefly, six 10 cm plates of cells were grown to about 80% confluence. Cells 
were collected by scraping, gently centrifuged, washed with hypotonic buffer [20mM 
Tris (pH 7.5), 3mM CaCl2, and 2mM MgCl2], and then resuspended in 5 packed cell 
volumes of hypotonic buffer and incubated on ice for 20 min. Swollen cells were 
homogenized in a Dounce homogenizer and centrifuged at low speed (500g) to 
pellet crude nuclei. The postnuclear supernatant was further processed as described 
below. The crude nuclear pellet was further purified by resuspension in 500l ER 
stripping buffer [10 mm Tris (pH 8.0), 3mM CaCl2, 2mM MgCl2, 0.1mM EDTA, 1mM 
dithiothreitol, and 0.5% Nonidet P-40], incubated on ice for 15 min, and then 
centrifuged at 500g for 5 min. The supernatant containing ER fragments originally 
associated with nuclei is combined with membrane pellet below. Purified nuclei were 
loosened by tapping and mixed with 1/3 packed cell volume high salt buffer [420mM 
NaCl and 20mM Tris (pH 7.5)] with for 30 min at 4oC. The resulting suspension was 
centrifuged for 20 min at 4oC at 16000g, and the supernatant, containing soluble 
nuclear proteins, was collected, diluted with an equal volume of hypotonic buffer, and 
collected as the nuclear fraction. The postnuclear supernatant obtained above was 
centrifuged at 16,000g for 20 min at 4oC. The supernatant was collected as the 
cytosolic fraction, and the pellet was collected as the crude ER/membrane fraction 
and re-suspended in the ER supernatant as collected above. All buffers contained a 
protease inhibitor cocktail (Complete Mini, Roche). Cytosolic, ER/membrane, and 
purified nuclear fractions were analyzed by western blotting using SULF1 and 
SULF2 antibodies. 
 
Immunocytochemical staining of cells: The pattern of SULF1/SULF2 expression 
in cell cultures was examined using rabbit peptide antibodies C (1/200) and D 
(1/100) to these enzymes described previously [10, 11, 14, 15]. The binding of 
primary antibodies was detected using goat anti-rabbit biotinylated IgG (1/400) 
followed by streptavidin conjugated Alexa Fluor 488 fluorochrome (1/400). The 
expression of tubulin using double immunofluorescence procedure was detected by 
Abcam rat anti tubulin (1/200) visualised by anti rat immunoglobulins linked to Alexa 
Fluor 594 fluorochrome (1/400). Cells treated with pre-immune rabbit sera were 
similarly incubated with fluorochrome-labelled secondary antibodies as controls (not 
shown). Cells with primary antibody dilutions were incubated overnight at 4°C 
followed by PBS rinses and secondary antibody incubations for 1hour each at room 
temperature. Antibody-labelled cells were mounted in fluorescent mounting medium 
(Sigma Aldrich) containing 2.5μg/ml DAPI for nuclear visualisation and photographed 
using a Leica DM4000B fluorescent microscope. Quantification of the individual 





1. Highly dynamic spatial and temporal expression of SULF1 and SULF2 in 
neuronal cells: A proportion of four neuronal cell lines C6,N2A, SHSY5Y and U87 
tested in this study did not only show the expression of SULF1 and SULF2 proteins 
in cytoplasm, its site of translation or the cell membrane, its site of cell signalling 
facilitation but also in a number of the nuclei (Figure 1) the proportion of which varied 
in different cell cultures. Further immunocytochemical analysis of C6 cell cultures 
indicated spatial and temporal changes in SULF1 and SULF2 expression to relate to 
the cell density at any given stage (Figure 2). The relationship to cell density became 
very apparent when the cells seeded at different densities showed preferential 
nuclear or membrane or both nuclear and membrane associated SULF1/SULF2 
expression.  For example, nuclear SULF1/SULF2 expression was usually observed 
during earlier stages of growth when the cells were actively proliferating. In C6 cells, 
maximum nuclear expression of SULF1/SULF2 was observed in nascent daughter 
nuclei pair with the elongated thinner shape and size of the nuclei being much 
smaller at this stage, as seen by DAPI staining (Figure 2). The area of 
SULF1/SULF2 expression during cell division usually extended into the perinuclear 
region but not into peripheral cytoplasm. The nuclear SULF1/SULF2 expression, 
however was transient as the SULF expression in the nucleus was rapidly down-
regulated following subsequent cellular growth.  The SULF1/SULF2 expression 
downregulation in the nucleus always first became apparent in the centre of the 
nucleus followed by down-regulation in the peripheral nucleus.  SULF1/SULF2 
proteins became undetectable in the nuclei soon after cell division and as the cell 
cultures became confluent.  The expression of these enzymes in high density 
cultures was thus usually restricted to only the cell membrane with little or no 
expression in the cytoplasm or the nuclei (Figure 2).  The correlation of 
SULF1/SULF2 translocation into cell nucleus with cell cycle was further highlighted 
by their correlation with expression of tubulin (Figure 3). Tubulin is a component of 
microtubules involved in the assembly of a mitotic spindle that ensures proper 
attachment of microtubules to chromosomes through kinetochores before cells enter 
anaphase and can segregate into daughter cells (Figure 3).  The cells for this 
experiment were treated with nocodazole for 16 hours and analysed at different time 
points following recovery. Nocodazole reversibly arrests cell cycle as it disrupts 
microtubule function by binding to β-tubulin. It suppresses microtubule dynamics by 
inducing microtubule depolymerization. The levels of SULF1 and SULF2 closely 
correlated with the levels of tubulin during nuclear localisation (Figure 3).  
2. Cell fractionation confirms SULF1 and SULF2 expression in the neuronal 
cell nuclei: Since the SULF1/SULF2 enzymes are known to facilitate cell signalling 
on the cell membrane and their expression in the nucleus was unexpected, we 
analysed the association of these enzymes with the nucleus further by 
immunoblotting analysis of membrane, cytosol and nuclear fractions of not only the 
C6 but also U87 and N2A cells. The immunoblotting analysis of C6 cell fractions 
showed no SULF1 or SULF2 expression in the soluble cytosol but the staining of two 
SULF1 as well as SULF2 bands in the cell membrane.  The molecular weights of two 
SULF1 bands were about 60 and 40kD while the size of membrane associated 
SULF2 was 70 and 45kD.  Unlike the membranous fraction the two major bands 
stained with the SULF1 antibody in the nucleus were of 125kD and 50kD although 
some weak staining was also observed with some other minor bands of intermediate 
mobility.  As was the case with C6 cells, no SULF1 or SULF2 expression was 
observed in the U87 cell cytosol but the SULF2 staining of the U87 membrane 
fraction showed the presence of two major bands of 70 and 50kD with a weaker 
staining of the 75kD. SULF2 in the nucleus also showed the presence of these two 
major bands and low levels of 100kD, 45kD and 33kD. SULF1 staining of U87 
membrane fraction similarly showed the presence of two major bands of 70 and 
48kD but also a weak staining of an additional smaller size band of 30kD. The U87 
nuclear fraction in contrast did not only show the presence of two major bands 
associated with the cell membrane but also low level expression of additional bands 
(125kD, 100kD and 30kD).  Immunoblotting of N2A cell fractions showed no SULF1 
expression in the cytosol but dark staining of 4 major bands of 125, 75, 40 and 20kd 
sizes in the membrane fraction.  While the level of SULF1 expression in the nuclear 
fraction was lower than in the membrane fraction, dark staining of three major bands 
of 72, 28 and 18kd was observed in the nuclear fraction that also included significant 
staining of a 125kD band. Immunoblotting of N2A cell membrane fraction with 
SULF2 antibody showed dark staining of 3 major bands of 72, 43 and 33kd 
molecular sizes that unlike the C6 and U87 cells also showed some expression of 
three SULF2 bands of 74, 63 and 33kD sizes in the cytosol fraction. N2A Nuclear 
fraction also showed a weaker but significant staining of a number of bands in similar 
molecular range although the darkest staining band was of 28 or 30kD. Nuclear 
SULF1/SULF2 expression was thus not only apparent by immunocytochemistry but 
also by immunoblotting procedure.  The SULF1/SULF2 profiles in the nuclei were 
more complex than their expression on the cell membrane indicating diverse or 
different role in the nucleus. The difference in molecular sizes may relate to further 
post-translational processing of these proteins [16].   
 
3. SULF1 and SULF2 expression is closely associated with the cell cycle: Since 
the distribution and level of SULF1/SULF2 expression appeared to vary from culture 
to culture, we next analysed the expression of these enzymes in synchronised cell 
cultures following a 16 hour mitotic block with nocodazole to investigate the changes 
in SULF1/SULF2 expression following release from the mitotic block. The 
nocodazole block at G2M phase of cell cycle led to a marked reduction in both 
SULF1/SULF2 expression but the levels of these enzymes gradually increased 
following recovery (Figures 5-7).  A number of cells showed nuclear SULF1/SULF2 
expression during early stages of recovery but with little or no nuclear SULF1/SULF2 
expression after 8 hours when the levels of these enzymes even on the cell 
membrane had decreased (Figures 6 & 7).  While flow cytometric analysis (Figure 5) 
showed the largest proportion of cells going through mitosis during earlier phase of 
1-2 hours, the maximum SULF1/SULF2 expression in these cell cultures was 
observed at 4 hours recovery using immunocytochemical quantitation by measuring 
pixels/area that does not distinguish between nuclear and cytoplasmic or 
membranous expression.  A number of cells, however, were observed with nuclear 
SULF1/SULF2 staining even at 4-hour recovery time. The highest level of 
cytoplasmic SULF1/SULF2 expression usually related to the larger size of the cells 
(Figures 6&7). Compared to 4 hour stage, only a small proportion of the cells 
showed larger size associated with darker cytoplasmic staining of SULF1 as well as 
SULF2 at 8 hours while the SULF1/SULF2 staining was generally restricted to only 
the cell membrane by 24 hours.  It is also clear that a proportion of the cells 
expressed no SULF1 or SULF2 during any stage of growth. This analysis of nuclear 
expression thus showed transient and highly dynamic relationship to cell cycle and 
the maximum level of nuclear SULF1/SULF2 expression appeared to relate to G2M 
stage of cell cycle.  Also apparent from this analysis was the increased expression of 
both SULF1/SULF2 during increasing cell size of C6 cells.  The variation in cell size 
during cell cycle was also apparent from the H&E staining of the C6 cells (Figure 8). 
The presence of dividing cells during recovery following nocodazome treatment was 
also apparent using the routine H&E stain. Quantitative changes in cells undergoing 
cell cycle following G2M block during different stages of recovery became apparent 
from the H&E analysis showing 0.63%+0.29% cells dividing at 0 hour, 3.38%+0.22% 
at 2 hours, 2.91%+0.30% at 4 hours, 1.28%+0.25% at 8 hours and 0.31%+0.16% 
cells dividing at 24 hours. The H&E stained cells were also used to determine the 
changes in cell size during recovery time following 16-hour nocodazole treatment 
(Figure 8) that showed cell size increase at 2, 4 and 8hours when compared with 0hr 
and 24hr. 
 
4. Nuclear expression of SULF1/SULF2 is prolonged in polyploid neuronal 
cells  Since the SULF1/SULF2 expression in the nucleus appeared downregulated 
following mitosis, we speculated that the expression of these enzymes in the nuclei 
of polyploid cells that fail to proceed to cytokinesis may continue to show their 
nuclear expression of these enzymes. The flow cytometric analysis indicated the 
presence of a fraction of C6 polyploid cells that light microscopy revealed to be large 
irregularly shaped cells with irregularly shaped nuclei becoming most apparent at 4 
hours of culture. We therefore examined the expression of SULF1/SULF2 in such 
cells at 4 hour recovery time following nocodazole treatment. The level of nuclear 
SULF1/SULF2 expression in such polyploid cells appeared to be generally higher as 
indicated by darker staining of these cells (cells indicated by arrows in Figure 9).  
While a large majority of diploid cells with single nucleus at 4 hours showed little or 
no SULF1/SULF2 expression, these enzymes persisted in the nuclei of polyploid 
cells for longer than in the normal diploid nuclei as their expression was still apparent 
at 4-hours unlike most diploid cells.  SULF1/SULF2 expression even in polyploid 
cells, however, was down-regulated gradually and thus did not relate to cytokinesis 
event since SULFs were eventually eliminated from the nuclei despite the failure of 
nuclear segregation. 
 
5. SULF1/SULF2 overexpression promotes while SULF1/SULF2 silencing 
inhibits cell division and their nuclear mobilisation: Since both SULF1 and 
SULF2 showed marked changes during cell division and cell growth, we further 
investigated the role of increased ectopic SULF1/SULF2 expression as well as their 
inhibition by siRNA knockdown in U87 and using neutralisation antibodies in C6 
cells. The ectopic expression of both SULF1 and SULF2 in U87 as well as C6 cells 
showed a significantly higher rate of cell proliferation and detection of increased 
number of cells showing nuclear SULF1/SULF2 expression (Figure 10). The 
overexpression of SULF1/SULF2 genes thus did not only show increased number of 
cells with nuclear expression of these enzymes but also, importantly, increased cell 
proliferation measured by increased cell number. This was markedly different when 
SULF1/SULF2 expression was inhibited by siRNA in U87 and C6 cells. Most such 
cells following siRNA knockdown showed little or no SULF1/SULF2 expression in the 
nuclei and only a low level expression restricted to only the cell membrane. Only a 
rare cell in such siRNA treated cultures showed any nuclear expression of 




DISCUSSION:   
 
It is now well established that both SULF1/SULF2 enzymes are located on the cell 
membrane where they facilitate cell signalling by promoting ligand receptor 
interaction through regulated de-sulfation of HSPGs [4, 5]. Their extracellular 
location was also apparent from their modified gene structure that did not only 
include a hydrophobic signal for secretion but also the presence of a highly basic 
hydrophilic domain at the C-terminal end that is lacking in all the intracellular 
sulfatases [4, 5]. This highly basic hydrophilic domain is ideally suited to dock these 
SULF enzymes to the cell membrane. Their site of action therefore was assumed to 
be entirely extracellular on the cell membrane.  Our earlier study of some neuronal 
tissues, however indicated the expression of these enzymes and particularly of 
SULF2 in the nuclei of some neuronal cells [9]. The present study confirms such 
unexpected localisation of both SULF1 and SULF2 enzymes in the nuclei of all four 
neuronal cell lines tested in this study. While SULF1/SULF2 enzymes on the cell 
membrane are known to desulfate HSPGs to facilitate certain cell signalling 
pathways the role of these enzymes in the nucleus is not known.  HSPGs, however, 
are known to be expressed in the nucleus in both sulphated and desulfated forms 
where they have been proposed to have multiple regulatory functions in the cell 
cycle, transcription and transport of cargo to the nucleus [17].  The differential levels 
of nuclear HSPG sulfation during all these nuclear activities [17] including cell cycle 
were thus attributed to the activities of different sulfotransferases. The present study 
demonstrates further editing of sulfotransferase regulated HSPG sulfation not only 
extracellularly on the cell membrane or ECM but also intracellularly in the nucleus 
during cell cycle. 
 
The present study shows that the level of SULF1/SULF2 expression in vitro growth 
of C6 cells was not static and not only quantitatively variable but also spatially 
dynamic as their localisation varied markedly during different stages of growth.  
Comparing quantitative levels of these enzymes without specifying the cell density or 
different stages of growth can thus be misleading as their levels continuously change 
during growth and varied culture conditions impacting growth. The unexpected 
observation in this study was the SULF1/SULF2 expression in the nuclei. The 
changes in SULF1/SULF2 expression may relate to changes in cell signalling 
promoting growth or some transcriptional activity. It is clear that cell signalling 
induced cell proliferation at least in some cells also extends to cell cycle itself.  What 
precise role the SULFs play in the nucleus is not clear but could desulfate HSPGs in 
the nucleus not only to facililtate cell proliferation but also to promote transcription or 
gene expression as level of HSPG sulfation has been demonstrated to impact all 
these activities. SULF1/SULF2 enzymes could thus regulate cell cycle as desulfation 
by these enzymes could regulate gene expression through regulation of transcription 
since HSPG sulfation is known to inhibit histone acetylation.  Acetylation of histones 
increases gene expression by transcriptional activation while deacetylation leads to 
reduced gene transcription. Nuclear HSPG desulfation by SULF1/SULF2 enzymes 
could thus increase transcription.  
 
The composition of HSPG and its sulfation status in the nucleus has the potential to 
influence cell division in a positive or a negative manner.  For example, a higher level 
of sulfation in the nucleus has been reported once the cells reach confluency in 
certain cell types [18] although this may not apply to all cell types. The 
downregulation of SULF1/SULF2 in the nuclei of C6 confluent cells and also their 
much reduced expression in the cytoplasm and the cell membrane in such high 
density cell cultures would also permit higher levels of sulfation that agrees with 
increased sulfation in the absence of de-sulfating enzymes during the lag/stationary 
phase of this cell line.  Down-regulation of SULF1/SULF2 enzymes leading to 
increased levels of sulfation thus can decrease or prevent cell proliferation and may 
explain why high levels of these enzymes are usually detected during fetal growth of 
most tissues with a few exceptions such as some neuronal and skeletogenic tissues 
[9, 19].   
 
High levels of both SULF1/SULF2 in the nucleus were observed during cell division 
in the present study that would induce decreased nuclear levels of HSPG sulfation 
thus enabling the cell cycle to progress through S, G2 and M phases. This further 
confirms that some cell types undergoing cell division reduce nuclear HSPG sulfation 
and could upregulate sulfation following next round of cell cycle. The SULF1/SULF2 
expression in the nucleus was thus highly dynamic showing a clear correlation 
between cell cycle and nuclear localization of these enzymes. The level of 
SULF1/SULF2 expression, however, was rapidly downregulated in the nucleus 
following cell division but SULF1/SULF2 suppression in the nucleus was not strictly 
related to cytokinesis since even the polyploid cells show slightly delayed but 
eventual downregulation of these enzymes similar to the diploid cells. 
 
Following cell division, the newly formed cell can prepare for next round of cell cycle 
by growing larger in size to accumulate cell mass, chromosomal DNA duplication 
and preparation for mitotic spindle during G1 but also some further growth taking 
place in size during S and G2 phase before undergoing a next cycle of mitosis 
ensuring that the cell size is not diminished with each cell cycle.  This was clearly 
apparent from the cell size change observed following peak of cell division that was 
particularly apparent at 4 hours of recovery following nocodazole block of C6 cell 
mitosis. It is not, however, clear why a high level of both SULF1 and SULF2 
accumulation was observed in the cytoplasm at this stage and whether it was related 
to some downstream intracellular signalling of extracellular mitogen promoted 
proliferation or its participation in mTOR cell signalling.  It is not clear if this results 
from some size sensor to determine if the cells are sufficiently large to commit to cell 
division and whether SULFs are involved in promoting cell size increase as indicated 
by their high level of cytoplasmic expression following cell division. It is possible that 
cells have an intracellular mechanism to sense environmental growth conditions. If 
conditions permit growth, the signalling centre will trigger mass accumulation by 
initiating synthesis of new protein. TOR is a central component of this signalling 
centre and is directly responsible for activating the protein synthesis machinery. The 
reason why high levels of SULF1/SULF2 expression at 4 hours may relate to cell 
signalling pathways involved in increasing cell size via mTOR pathway is not clear.     
 
The changes in SULF1/SULF2 in response to cell cycle show some similarity to 
changes in Hippo pathway.  For example, cells that are preparing for a next round of 
cell cycle are inhibited by the hippo pathway that is inhibited by increased cell 
number and therefore abrogating further cell division. Hippo pathway promotes cell 
cycle but is switched off following cell contact inhibition i.e. when the cell density 
increases.  It is, however not clear whether these two pathways act independently or 
if they are related to each other. 
The highly dynamic spatial and temporal changes of expression during cellular 
growth thus highlights the multiple tasks of both SULF1/SULF2 enzymes not 
restricted to only extracellular cell signalling. Importantly, our findings introduce a 
novel role for these enzymes in cell division although the precise mechanism of their 
action in the nucleus remains to be determined. 
FIGURE LEGENDS: 
Figure 1: Immunocytochemical detection of SULF1 and SULF2 proteins in 4 
different neuronal cell lines demonstrates their nuclear expression in a sub-set of 
cells as indicated by arrows. 
Figure 2: Immunocytochemical detection of SULF1 in low density (A) and high 
density (B, C) C6 cell cultures.  A,B and C show Sulf1 staining superimposed with 
DAPI while A1,B1 and C1 show only DAPI staining to highlight the distinctive nuclear 
morphology following cell division. The nuclear comparison also highlights the 
broader expression of SULF1 around the nucleus as pointed out by the arrows.  
Figure 3: The correlation of SULF1 (A) and SULF2 (D) expression with localisation 
of tubulin involved in mitotic spindle formation during cell division in C6 cells 
examined at 4 hours recovery time following cell cycle arrest with nocodazole.  
Spindle formation by microtubules in this figure is indicated by arrows and asterisks 
(B).  DAPI stain highlights the normal and abnormal nuclear morphology when nuclei 
fail to separate in some polyploidy cells (nuclei indicated by arrows and asterisks in 
C). The cells showing high level of SULF1 and SULF2 nuclear expression correlating 
with tubulin are indicated by arrow with a circle.Figure 4: Identification of both 
SULF1 and SULF2 in not only cell membrane (M) but also nuclear (Nuc) fractions of 
C6, U87 and N2A cells with little expression in cytosol (C) using immunoblotting 
procedure. 
Figure 5: A: Freshly passaged C6 cells were blocked, 24 hours after culturing in 
complete growth medium, at the G2/M stage using 200ng/ml of nocodazole for 16 
hours before cells were released from the block by addition of fresh media and cells 
collected at various time-points and DNA content was analysed by flow cytometry 
after staining with propidium-iodide. Cell cycle profiles at these time points (0, 1, 3 4, 
6 and 8hr) are presented as histograms. Asynchronous, normally cultured cells 
(Asyn) were included as controls. Data shown are representative of three 
independent experiments with duplicate observations per time-point. B: Percentages 
of cells in different stages of the cell cycle are represented by bar graphs. Average 
fluorescence of cells stained for SULF2 after nocodazole block and release as in A 
at the different stages of the cell cycle is presented as bar graphs. C: Changes in 
levels of SULF1 and SULF2 expression measured using volocity software during 
different time intervals of recovery following 16-hour Nocodazole treatment.  
(a=p<0.0001, b=p<0.001, c= p<0.01, d=p<0.05) 
 
Figure 6: Changes in levels and spatial expression pattern of SULF1 during different 
time intervals of recovery following 16-hour nocodazole treatment of C6 cells 
including an untreated control (C). 
Figure 7: Changes in levels and spatial expression pattern of SULF2 during different 
time intervals of recovery following 16-hour nocodazole treatment of C6 cells 
including an untreated control (C). 
Figure 8: Changes in cell size and cell division using H&E stain during different time 
intervals of recovery following 16-hour nocodazole treatment of C6 cells including an 
untreated control (C). Cell size from H&E stained cells was measured using ImageJ 
software at indicated time points (n= 25 measurements per field, 3 fields per time 
point). (a, b, c : p< 0001)  
Figure 9: SULF1 and SULF2 expression in polyploid cells and those cells in which 
nuclei failed to move apart show higher level of expression and delayed nuclear 
suppression 
Figure 10: Sulf1 and Sulf2 gene over-expression achieved by transfection increased 
cell proliferation and the levels of SULF1 and SULF2 protein expression in 
transfected cells.  Sulf1/Sulf2 inhibition using si-RNA transfection for U87 cells and 
by using SULF1 (C) and SULF2 (D) neutralisation antibodies for C6 cells reduced 
cell proliferation as also confirmed by reduced levels of protein detected by antibody 
stain. The histograms demonstrate the quantitative differences in the levels of 
SULF1 and SULF2 following ectopic over-expression and inhibition as determined by 
using volocity software.  **p=0.001, *p=0.01. 
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